Primer: LifeMD (LFMD US) - Jan 2026
LifeMD is rapidly scaling its direct-to-consumer (DTC) telehealth platform, demonstrating a strong revenue growth trajectory driven by an...
230 Views
Biopharma Week in Review - Macro and M&A Boost Biotech; NVO Moves to Slow LLY Obesity Lead
Biotech fared better than pharma, as macro trends mostly favored growth stocks and LLY weakness pressured the large cap group.
285 Views
Biopharma Week in Review - March 10, 2025
Market uncertainty and further disruptions at health agencies led to continued divergence between SMID-cap and large biopharma, as investors sought...
276 Views
Biopharma Week in Review - February 24, 2025
Vaccine makers (PFE, MRNA, BNTX, NVAX) had an up-and- down week, as the HHS postponed the CDC’s first scheduled ACIP (vaccine experts panel)...
259 Views
Biopharma Week in Review - January 6, 2025
On the obesity front, NVO’s CagriSema fell short of expectations, while the FDA reaffirmed LLY’s GLP-1 shortage resolution, bearing bad news for...
294 Views